¿Podrán los nuevos fármacos frenar la epidemia mundial de la obesidad y el sobrepeso?
Open Access
- 25 November 2022
- journal article
- editorial
- Published by Elsevier in Atencion Primaria
- Vol. 55 (1) , 102518
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With ObesityGastroenterology, 2022
- Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine, 2022
- Has the Prevalence of Childhood Obesity in Spain Plateaued? A Systematic Review and Meta-AnalysisInternational Journal of Environmental Research and Public Health, 2022
- Obesity: global epidemiology and pathogenesisNature Reviews Endocrinology, 2019
- The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission reportThe Lancet, 2019
- Challenging assumptions in obesity researchBMJ, 2017
- Association of a Genetic Risk Score With Body Mass Index Across Different Birth CohortsJAMA, 2016
- Prevalencia de obesidad general y obesidad abdominal en la población adulta española (25–64 años) 2014–2015: estudio ENPERevista Espanola de Cardiologia, 2016
- Prevalence of General Obesity and Abdominal Obesity in the Spanish Adult Population (Aged 25–64 Years) 2014–2015: The ENPE StudyRevista Española de Cardiología (English Edition), 2016